Cargando…
Patient-Derived In Vitro Models for Drug Discovery in Colorectal Carcinoma
Lack of relevant preclinical models that reliably recapitulate the complexity and heterogeneity of human cancer has slowed down the development and approval of new anti-cancer therapies. Even though two-dimensional in vitro culture models remain widely used, they allow only partial cell-to-cell and...
Autores principales: | Ramzy, George M., Koessler, Thibaud, Ducrey, Eloise, McKee, Thomas, Ris, Frédéric, Buchs, Nicolas, Rubbia-Brandt, Laura, Dietrich, Pierre-Yves, Nowak-Sliwinska, Patrycja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352800/ https://www.ncbi.nlm.nih.gov/pubmed/32486365 http://dx.doi.org/10.3390/cancers12061423 |
Ejemplares similares
-
Platform combining statistical modeling and patient-derived organoids to facilitate personalized treatment of colorectal carcinoma
por: Ramzy, George M., et al.
Publicado: (2023) -
FOLFOXIRI Resistance Induction and Characterization in Human Colorectal Cancer Cells
por: Ramzy, George M., et al.
Publicado: (2022) -
Forcing dividing cancer cells to die; low‐dose drug combinations to prevent spindle pole clustering
por: Ducrey, Eloise, et al.
Publicado: (2021) -
Physical activity programmes for patients undergoing neo-adjuvant chemoradiotherapy for rectal cancer: A systematic review and meta-analysis
por: Latrille, Marianne, et al.
Publicado: (2021) -
Optimized low‐dose combinatorial drug treatment boosts selectivity and efficacy of colorectal carcinoma treatment
por: Zoetemelk, Marloes, et al.
Publicado: (2020)